Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 69

Sort by

Sort Order Select

Journal Articles

The Impact of Frailty on Outcomes and Quality of Life in Allogeneic Hematopoietic Cell Transplantation: Summary of Results from a Collaborative Prospective Study Conducted on Behalf of the Geth-TC

Blood (2024) 144 (Supplement 1): 405.

https://doi.org/10.1182/blood-2024-210022

Published: 2024

Journal Articles

Treatment with Siltuximab for Short Term Complications after Chimeric Antigen Receptor T-Cell Therapy: A Multicenter Retrospective Analysis

Jose M. Sanchez-Pina, Pablo Silva, Lucía López-Corral, Anabelle Chinea, Ana Africa Martin Lopez, Nuria Martinez-Cibrian, Rafael Hernani, Victor Noriega, Silvia Filaferro, Pascual Balsalobre, Maria Calbacho, Antonio Pérez-Martínez, Pere Barba, Mi Kwon

Blood (2024) 144 (Supplement 1): 7220.

https://doi.org/10.1182/blood-2024-207963

Published: 2024

Journal Articles

Current Prophylaxis and Treatment of Gvhd: Analysis of a Large Real-World Cohort. Spanish Group of Hematopoietic Transplantation and Cellular Therapy (GETH/TC)

Blood (2024) 144 (Supplement 1): 3531.

https://doi.org/10.1182/blood-2024-203251

Published: 2024

Journal Articles

Impact of Ptcy on Early Cardiac Toxicity after HLA-Matched Allo-HCT in Patients with Acute Myeloid Leukemia. Study on Behalf of the Grupo Español De Trasplante Hematopoyético y Terapia Celular (GETH-TC)

Blood (2024) 144 (Supplement 1): 2108.

https://doi.org/10.1182/blood-2024-205181

Published: 2024

Journal Articles

Frailty's Impact on CAR T-Cell Therapy Outcomes in Patients with Lymphoprolipherative Disorders: Insights from a Spanish Multicenter Pilot Study Conducted on Behalf of the Geth-CT

Blood (2024) 144 (Supplement 1): 3757.

https://doi.org/10.1182/blood-2024-205568

Published: 2024

Journal Articles

Frailty and Outcomes in Multiple Myeloma Patients Eligible for Autologous Hematopoietic Cell Transplantation: A Prospective Study of the Grupo Español De Trasplante Hematopoyético y Terapia Celular (GETH-TC)

Blood (2024) 144 (Supplement 1): 5148.

https://doi.org/10.1182/blood-2024-210442

Published: 2024

Journal Articles

Incidence, Clinical Risk Factors, and Biomarkers of SOS/VOD Following Allogeneic HSCT in Adults: A Real-Life Study By the Spanish Group of Hematopoietic Stem Cell Transplantation and Cell Therapy (GETH-TC)

Blood (2024) 144 (Supplement 1): 4869.

https://doi.org/10.1182/blood-2024-206887

Published: 2024

Journal Articles

Cytokine Release Syndrome after Allogeneic Stem Cell Transplantation with Post Transplant Cyclophosphamide

Laura Solán, PhD, Elena Landete, MD, Rebeca Bailén, MD, Nieves Dorado, MD, Pascual Balsalobre, PhD, David Serrano, MD, Carolina Martínez-Laperche, Javier Anguita, MD PhD, Jose Luis Díez-Martín, MD PhD, Mi Kwon

Blood (2018) 132 (Supplement 1): 3367.

https://doi.org/10.1182/blood-2018-99-111173

Published: 2018

Journal Articles

Leukemogenesis in Seven Donor Cell Derived Myeloid Neoplasms Patients. Whole Exome Sequencing Reveals Clonal Dynamics

Julia Suárez González, Juan Carlos Triviño, Mi Kwon, Angela Figuera Alvarez, MD PhD, Guiomar Bautista, Jose Garcia-Marco, MD PhD, Antonio Balas, Jose Luis Vicario, Francisco José Ortuño, Raul Teruel Montoya, PhD, Jose María Álamo, Pascual Balsalobre, PhD, José Luís Díez Martín, MD, Carolina Martínez-Laperche, Ismael Buño, PhD

Blood (2018) 132 (Supplement 1): 2752.

https://doi.org/10.1182/blood-2018-99-118894

Published: 2018

Journal Articles

Post-Transplant Cyclophosphamide Versus MTX-CSA As Gvhd Prophylaxis in HLA-Identical Sibling HSCT

Rebeca Bailén, MD, Maria-Jesús Pascual, MD, Pascual Balsalobre, PhD, Anabel Gallardo-Morillo, MD, Abel García-Sola, MD, David Serrano, MD, Javier Anguita, MD PhD, Ismael Buño, PhD, Nieves Dorado Herrero, MD, Laura Solán, PhD, Jose Díez-Martín, MD PhD, Mi Kwon

Blood (2018) 132 (Supplement 1): 3394.

https://doi.org/10.1182/blood-2018-99-110551

Published: 2018

Journal Articles

Weekly Screening for Multidrug-Resistant Organisms Identifies High Number of Colonizations in Patients Undergoing Stem Cell Transplantation

Silvia Monsalvo, Pascual Balsalobre, PhD, Nieves Dorado Herrero, MD, Laura Solán, PhD, Ana Fernandez-Cruz, MD, Marina Machado, MD, Maria Dolores Vigil-Escribano, MD, Javier Anguita, MD PhD, Jose Luis Díez-Martín, MD PhD, Mi Kwon

Blood (2018) 132 (Supplement 1): 5703.

https://doi.org/10.1182/blood-2018-99-118713

Published: 2018

Journal Articles

Serial Lineage Chimerism Analysis Improves Early Diagnosis of Graft Failure after Allogeneic HSCT

Ignacio Gómez-Centurión, MD, Mi Kwon, Pascual Balsalobre, PhD, David Serrano, MD, Nieves Dorado Herrero, MD, Laura Solán, PhD, María Chicano Lavilla, PhD, Diego Carbonell, Mr, Jose Luis Díez-Martín, MD PhD, Carolina Martínez-Laperche, Ismael Buño, PhD

Blood (2018) 132 (Supplement 1): 5704.

https://doi.org/10.1182/blood-2018-99-114945

Published: 2018

Journal Articles

Invasive Fungal Infection in the Setting of Peripheral Blood Non-Manipulated Haploidentical Stem Cell Transplantation with Postransplant Cyclophosphamide

Nieves Dorado, MD, Gillen Oarbeascoa, MD, Miguel Argüello, MD, Pascual Balsalobre, PhD, David Serrano, MD, Carolina Martínez-Laperche, Rebeca Bailén, MD, Javier Anguita, MD PhD, Jose Luis Díez-Martín, MD PhD, Mi Kwon

Blood (2018) 132 (Supplement 1): 5710.

https://doi.org/10.1182/blood-2018-99-118765

Published: 2018

Journal Articles

Impact of Early Immune Reconstitution after Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide

Nieves Dorado, MD, Ana Pérez-Corral, MD PhD, Mi Kwon, Laura Solán, MD, Rebeca Bailén, MD, Cristina Pascual, MD PhD, David Serrano, MD, Javier Anguita, MD PhD, Pascual Balsalobre, PhD, Carolina Martínez-Laperche, Jose Luis Díez-Martín, MD PhD

Blood (2018) 132 (Supplement 1): 2118.

https://doi.org/10.1182/blood-2018-99-119601

Published: 2018

Journal Articles

ST2 As a Biomarker of Non-Relapse Mortality after HLA-Haploidentical SCT with High-Dose Post-Transplantation Cyclophosphamide

Laura Solán, PhD, Carolina Martínez-Laperche, PhD, Mi Kwon, Diego Carbonell, Pascual Balsalobre, David Serrano, María Chicano, PhD, Julia Suárez-González, Javier Anguita, MD PhD, Jorge Gayoso, MD, Ismael Buño, Jose L. Diez-Martin, MD PhD

Blood (2017) 130 (Supplement 1): 3313.

https://doi.org/10.1182/blood.V130.Suppl_1.3313.3313

Published: 2017

Journal Articles

Immune Reconstitution Impact on Overall Survival after Hematopoietic Haploidentical Stem Cell Transplantation

Ana Perez-Corral, MD PhD, Nieves Dorado, MD, Virginia Pradillo, MD, Jorge Gayoso, MD, Javier Anguita, MD PhD, Mi Kwon, MD, Crsitina Pascual, MD PhD, David Serrano, MD, Juan Churruca, MD, Pascual Balsalobre, Carolina Martinez-Laperche, PhD, Jose Luis Diez-Martin, MD PhD

Blood (2016) 128 (22): 5779.

https://doi.org/10.1182/blood.V128.22.5779.5779

Published: 2016

Journal Articles

Autologous Stem Cell Transplantation (autoSCT) for HIV-Associated Lymphoma in the Era of Combination Antiretroviral Therapy (cART): A Retrospective Analysis of the EBMT Lymphoma Working Party

Kai Huebel, MD, Alessandro Re, MD, Ariane Boumendil, PhD, Herve Finel, Marcus Hentrich, Mariagrazia Michieli, Edward Kanfer, Jose Luis Diez-Martin, MD PhD, Pascual Balsalobre, Laure Vincent, Wilfried Schroyens, MD PhD, Josep Maria Ribera Santasusana, Nicolaus Kröger, MD, Xaver Schiel, MD, Kirsty J Thomson, MD, Jorge Sierra, MD, Aida Botelho Sousa, Silvia Montoto, MD, Peter Dreger, MD

Blood (2016) 128 (22): 2257.

https://doi.org/10.1182/blood.V128.22.2257.2257

Published: 2016

Journal Articles

Infectious Complications and Mortality after Autologous Stem Cell Transplantation for Lymphomas: A Comparison Between HIV-Infected and HIV-Negative Patients

Juan Churruca, Mariana Bastos-Oreiro, Julia Suárez González, Carolina Martinez-Laperche, Pascual Balsalobre, Pilar Miralles, Juan Berenguer, David Serrano, MD, Mi Kwon, MD, Jorge Gayoso, MD, Jose Luis Diez-Martin, MD PhD

Blood (2016) 128 (22): 2258.

https://doi.org/10.1182/blood.V128.22.2258.2258

Published: 2016

Journal Articles

Antithymocyte Globulin-Based Prophylaxis for Graft Versus Host Disease Compared to Post-Transplant Cyclophosphamide-Based Prophylaxis in Matched Unrelated Donor Transplantation

Sara Redondo Velao, MD, Mi Kwon, MD, Diana Champ, MD, MJ Pascual Cascon, Pascual Balsalobre, J Diez, I Vidales Mancha, David Serrano, MD, Noemi Fernandez, Javier Anguita, MD PhD, Ismael Buño, PhD, Jorge Gayoso, MD, Jose Luis Diez-Martin, MD PhD

Blood (2016) 128 (22): 2307.

https://doi.org/10.1182/blood.V128.22.2307.2307

Published: 2016

Journal Articles

Myeloablative Conditioning Haploidentical Stem Cell Transplantation (MAC-HAPLO) with Post-Transplant Cyclophosphamide (PTCy) As GvHD Prophylaxis in High Risk Leukemias/Myelosdysplastic Syndromes (MDS): Geth Experience

Blood (2016) 128 (22): 4690.

https://doi.org/10.1182/blood.V128.22.4690.4690

Published: 2016

NARROW

The Impact of Frailty on Outcomes and Quality of Life in Allogeneic Hematopoietic Cell Transplantation: Summary of Results from a Collaborative Prospective Study Conducted on Behalf of the Geth-TC

Treatment with Siltuximab for Short Term Complications after Chimeric Antigen Receptor T-Cell Therapy: A Multicenter Retrospective Analysis

Current Prophylaxis and Treatment of Gvhd: Analysis of a Large Real-World Cohort. Spanish Group of Hematopoietic Transplantation and Cellular Therapy (GETH/TC)

Impact of Ptcy on Early Cardiac Toxicity after HLA-Matched Allo-HCT in Patients with Acute Myeloid Leukemia. Study on Behalf of the Grupo Español De Trasplante Hematopoyético y Terapia Celular (GETH-TC)

Frailty's Impact on CAR T-Cell Therapy Outcomes in Patients with Lymphoprolipherative Disorders: Insights from a Spanish Multicenter Pilot Study Conducted on Behalf of the Geth-CT

Frailty and Outcomes in Multiple Myeloma Patients Eligible for Autologous Hematopoietic Cell Transplantation: A Prospective Study of the Grupo Español De Trasplante Hematopoyético y Terapia Celular (GETH-TC)

Incidence, Clinical Risk Factors, and Biomarkers of SOS/VOD Following Allogeneic HSCT in Adults: A Real-Life Study By the Spanish Group of Hematopoietic Stem Cell Transplantation and Cell Therapy (GETH-TC)

Cytokine Release Syndrome after Allogeneic Stem Cell Transplantation with Post Transplant Cyclophosphamide

Leukemogenesis in Seven Donor Cell Derived Myeloid Neoplasms Patients. Whole Exome Sequencing Reveals Clonal Dynamics

Post-Transplant Cyclophosphamide Versus MTX-CSA As Gvhd Prophylaxis in HLA-Identical Sibling HSCT

Weekly Screening for Multidrug-Resistant Organisms Identifies High Number of Colonizations in Patients Undergoing Stem Cell Transplantation

Serial Lineage Chimerism Analysis Improves Early Diagnosis of Graft Failure after Allogeneic HSCT

Invasive Fungal Infection in the Setting of Peripheral Blood Non-Manipulated Haploidentical Stem Cell Transplantation with Postransplant Cyclophosphamide

Impact of Early Immune Reconstitution after Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide

ST2 As a Biomarker of Non-Relapse Mortality after HLA-Haploidentical SCT with High-Dose Post-Transplantation Cyclophosphamide

Immune Reconstitution Impact on Overall Survival after Hematopoietic Haploidentical Stem Cell Transplantation

Autologous Stem Cell Transplantation (autoSCT) for HIV-Associated Lymphoma in the Era of Combination Antiretroviral Therapy (cART): A Retrospective Analysis of the EBMT Lymphoma Working Party

Infectious Complications and Mortality after Autologous Stem Cell Transplantation for Lymphomas: A Comparison Between HIV-Infected and HIV-Negative Patients

Antithymocyte Globulin-Based Prophylaxis for Graft Versus Host Disease Compared to Post-Transplant Cyclophosphamide-Based Prophylaxis in Matched Unrelated Donor Transplantation

Myeloablative Conditioning Haploidentical Stem Cell Transplantation (MAC-HAPLO) with Post-Transplant Cyclophosphamide (PTCy) As GvHD Prophylaxis in High Risk Leukemias/Myelosdysplastic Syndromes (MDS): Geth Experience

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only